Cisplatin-induced AKI risk stratification and safety of dose reduction in urothelial carcinoma patients with renal impairment. - Yamamoto S; Higa K; Kurokawa K; Bamba H; Kanaoka S; Nakamura K (Actas urologicas espanolas, 2025)